Noncoding RNAs (ncRNAs), including microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) among others, have attracted a great deal of attention for their potential role as master regulators of gene expression and as therapeutic targets. This review focuses on recent advances on the role of ncRNAs in the pathogenesis, diagnosis and treatment of diseases of the cholangiocytes (i.e. cholangiopathies)
International audienceCholangiocarcinoma (CCA) is the second primary hepatic malignancy after hepato...
Cholangiocarcinoma (CCA) is an aggressive malignancy that arises from damaged epithelial cells, chol...
Recently, there is ample evidence suggesting the important role of microRNAs (miRNAs) in autoimmune ...
Cholangiopathies are a group of rare, devastating diseases that arise from damaged cholangiocytes, t...
The cholangiopathies are a group of liver diseases resulting from different etiologies but with the ...
Cholangiocarcinomas (CCAs) are tumors with a dismal prognosis. Early diagnosis is a key challenge be...
Abstract: The cholangiopathies are a group of liver diseases resulting from different etiologies but...
Cholangiocarcinoma (CCA) is one of the most common tumors with high malignancy. Its incidence is inc...
Long non-coding RNAs (lncRNAs) are RNAs with lengths exceeding 200 nucleotides that are not translat...
Abstract Background Long noncoding RNAs (lncRNAs) are known to play important roles in different cel...
Cholangiocarcinomas (CCAs) are tumors with a dismal prognosis. Early diagnosis is a key challenge be...
Bile-duct cancers (BDC) are a group of solid tumors arising from the biliary tree. Despite their cla...
Cholangiocarcinoma is a highly aggressive cancer with a dismal prognosis and limited resectability. ...
Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease associated with autoimmune ...
BackgroundCholangiocarcinoma is characterized by late diagnosis and a poor survival rate. MicroRNAs ...
International audienceCholangiocarcinoma (CCA) is the second primary hepatic malignancy after hepato...
Cholangiocarcinoma (CCA) is an aggressive malignancy that arises from damaged epithelial cells, chol...
Recently, there is ample evidence suggesting the important role of microRNAs (miRNAs) in autoimmune ...
Cholangiopathies are a group of rare, devastating diseases that arise from damaged cholangiocytes, t...
The cholangiopathies are a group of liver diseases resulting from different etiologies but with the ...
Cholangiocarcinomas (CCAs) are tumors with a dismal prognosis. Early diagnosis is a key challenge be...
Abstract: The cholangiopathies are a group of liver diseases resulting from different etiologies but...
Cholangiocarcinoma (CCA) is one of the most common tumors with high malignancy. Its incidence is inc...
Long non-coding RNAs (lncRNAs) are RNAs with lengths exceeding 200 nucleotides that are not translat...
Abstract Background Long noncoding RNAs (lncRNAs) are known to play important roles in different cel...
Cholangiocarcinomas (CCAs) are tumors with a dismal prognosis. Early diagnosis is a key challenge be...
Bile-duct cancers (BDC) are a group of solid tumors arising from the biliary tree. Despite their cla...
Cholangiocarcinoma is a highly aggressive cancer with a dismal prognosis and limited resectability. ...
Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease associated with autoimmune ...
BackgroundCholangiocarcinoma is characterized by late diagnosis and a poor survival rate. MicroRNAs ...
International audienceCholangiocarcinoma (CCA) is the second primary hepatic malignancy after hepato...
Cholangiocarcinoma (CCA) is an aggressive malignancy that arises from damaged epithelial cells, chol...
Recently, there is ample evidence suggesting the important role of microRNAs (miRNAs) in autoimmune ...